https://edhs-206inhibitor.com/....any-multi-residue-lo
Amount of proof Prognostic Degree III. See Instructions for Authors for a complete description of amounts of research.Goals To describe the event of malabsorption (MA) in hepatocellular carcinoma (HCC) patients under sorafenib, the potential commitment with pancreatic insufficiency (PI), and the role of pancreatic enzymes supplementation. Background With the increasing options of second-line systemic therapies for HCC, the recognition of drug intolerance making use of practical tools is cr
Like
Comment
Share
